Prostate Cancer :: Selenium reduces prostate cancer risks
High selenium levels may be protective against prostate cancer, a new study reported in the American Journal of Clinical Nutrition.
High selenium levels may be protective against prostate cancer, a new study reported in the American Journal of Clinical Nutrition.
Millions of middle-aged and older men experience the symptoms of an enlarged prostate multiple times during the day and night.
More than 90 percent of men who receive appropriate radiation dose levels with permanent radiation seed implants to treat their prostate cancer are cured of their cancer eight years after diagnosis, according to a study released in the February 1 issue of the International Journal for Radiation Oncology*Biology*Physics, the official journal of ASTRO.
A new University of Illinois study shows that tomatoes and broccoli are better at shrinking prostate tumors when both are part of the daily diet than when they’re eaten alone.
A drug based on vitamin D and is given to patients in the advanced stages of prostate cancer along with chemotherapy drugs could be availiable by 2009. Vitamin D from sunlight improves the prognosis of certain cancers, but taking natural levels of the vitamin has no effect. Novacea, the company that makes Asentar, produced a novel formulation that reproduces the healing effect without the dangerous side-effects of a vitamin D overdose.
A new University of Illinois study shows that tomatoes and broccoli — two vegetables known for their cancer-fighting qualities — are better at shrinking prostate tumors when both are part of the daily diet than when they’re eaten alone.
A new study published in the Journal of Urology revealed that the prostate cancer treatments shorten penis. Men who receive combination treatment with hormone therapy plus radiation for local or locally advanced prostate cancer may experience a significant reduction in penile length.
There is a “strong correlation” between obesity and the risk of dying from prostate cancer, a study has revealed. The US National Cancer Institute study examined the incidence and outcomes of prostate cancer in 287,760 men aged between 50 and 71.
Seventy-four percent of men treated with a combination of radiation seed implants and external beam radiation therapy for prostate cancer are cured of their disease 15 years following their treatment, according to a study released today in the International Journal of Radiation Oncology*Biology*Physics, the official journal of ASTRO.
In a new study to determine if genes on the Y chromosome are involved in prostate cancer, researchers at the Mailman School of Public Health in conjunction with Hebrew University found that men who had only daughters had a higher risk of prostate cancer than men who had at least one son. The results further indicate that the relative risk of prostate cancer decreases as the number of sons increases.